Inflation Reduction Act and US drug pricing

被引：12
|
作者：
Sarpatwari, Ameet [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regular Hu Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2022年 / 378卷
关键词：
UNITED-STATES;
D O I：
10.1136/bmj.o2163
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Impending Relief for Medicare Beneficiaries - The Inflation Reduction Act
    Dusetzina, Stacie B.
    Huskamp, Haiden A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1437 - 1439
  • [42] Pills, Bills, and Capitol Hill: Reevaluating the Prescription Drug "Rebate Rule" in Light of the Inflation Reduction Act
    Gilberg, Lindsey J.
    IOWA LAW REVIEW, 2023, 109 (01) : 351 - 375
  • [43] A summit on amplifying voices of patients, caregivers, and people with disabilities in Inflation Reduction Act drug price negotiations
    Miller, Maxine
    van Geertruyden, Sara
    Saxton, M. Claire
    Savage, Courtney Yohe
    Weir, Debbie
    Werner, Sally
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (03): : 247 - 251
  • [44] New Eenergy Chinese enterprises Set up Factories in South Korea in Response to the US Inflation Reduction Act
    China Nonferrous Metals Monthly, 2023, (08) : 1 - 2
  • [45] The (un)just transition in ecomodernist climate policy: Critical analysis of social inequities in the US Inflation Reduction Act
    Gounder, Babu
    Brown, C. Taylor
    CRITICAL SOCIAL POLICY, 2025, 45 (01) : 165 - 176
  • [46] Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act
    Grabowski, Henry
    Long, Genia
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 463 - 472
  • [47] The new US A Food and Drug Act
    不详
    BRITISH MEDICAL JOURNAL, 1938, 2 : 457 - 458
  • [48] Third world drug pricing: pharma companies act
    不详
    MANUFACTURING CHEMIST, 2001, 72 (04): : 15 - 15
  • [49] Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act
    Narasimmaraj, Prihatha R.
    Oseran, Andrew
    Tale, Archana
    Xu, Jiaman
    Essien, Utibe R.
    Kazi, Dhruv S.
    Yeh, Robert W.
    Wadhera, Rishi K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (15) : 1491 - 1501
  • [50] INFLATION REDUCTION ACT: ASSESSING THE IMPACT FOR NEW DRUG DEVELOPMENT, LAUNCH, LIFE CYCLE MANAGEMENT AND LOSS OF EXCLUSIVITY
    Briggs, S.
    Francois, C.
    Auger, E.
    Busch, A.
    VALUE IN HEALTH, 2023, 26 (06) : S228 - S228
12345